Yıl: 2023 Cilt: 8 Sayı: 2 Sayfa Aralığı: 115 - 120 Metin Dili: İngilizce DOI: 10.4274/cjms.2023.2022-74 İndeks Tarihi: 02-06-2023

COVID-19 Associated Brain Fog and Neurocognitive Assessment

Öz:
BACKGROUND/AIMS: In this study, we aimed to make detailed neurocognitive assessments of patients who presented with brain fog after coronavirus disease-2019 (COVID-19) infection and to investigate their complaints after one-year of follow-up. MATERIALS AND METHODS: Patients who had COVID-19, which was not severe enough to require intensive care, and who subsequently applied to neurology due to cognitive complaints were included in this study. A neurocognitive test battery was applied to those patients who agreed to detailed examination (n=16). This battery consisted of the following tests: mini-mental test, enhanced cued recall test, phonemic fluency, categorical fluency, digit span, counting the months backwards, clock-drawing, arithmetic operations, trail-making, cube copying, intersecting pentagons, and the interpretation of proverbs and similes. At one year, the patients were called by phone and questioned as to whether their cognitive complaints had persisted. Those patients with ongoing complaints were invited to the hospital and re-evaluated via cognitive tests. The results are presented in comparison with age-matched healthy controls (n=15). RESULTS: Almost all of the patients’ scores were within the “normal” range. The Spontaneous recall of the patients was statistically significantly lower than the controls (p=0.03). Although there were decreases in executive functions and central processing speed (trail making-A, trail making-B and reciting the months backwards tests) in the patient group, these differences were not statistically significant (p=0.07; p=0.14 and p=0.22, respectively) compared to the controls. We observed that the cognitive complaints of the patients had disappeared by the one-year follow-up. CONCLUSION: In our patients with brain fog, most of whom had mild COVID-19, we observed that among all cognitive functions, memory domain was most affected compared to the controls. At the one-year follow-up, COVID-related brain fog had disappeared.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Taskiran-Sag A, Eroğlu E, Canlar Ş, Poyraz BM, Özülken K, Mumcuoğlu T, et al. Subacute neurological sequelae in mild COVID-19 outpatients. Tuberk Toraks. 2022; 70(1): 27-36.
  • 2. Tabacof L, Tosto-Mancuso J, Wood J, Cortes M, Kontorovich A, McCarthy D, et al. Post-acute COVID-19 Syndrome Negatively Impacts Physical Function, Cognitive Function, Health-Related Quality of Life, and Participation. Am J Phys Med Rehabil. 2022; 101(1): 48-52.
  • 3. Heneka MT, Golenbock D, Latz E, Morgan D, Brown R. Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alzheimers Res Ther. 2020; 12(1): 69.
  • 4. Apple AC, Oddi A, Peluso MJ, Asken BM, Henrich TJ, Kelly JD, et al. Risk factors and abnormal cerebrospinal fluid associate with cognitive symptoms after mild COVID-19. Ann Clin Transl Neurol. 2022; 9(2): 221-6.
  • 5. Hellmuth J, Barnett TA, Asken BM, Kelly JD, Torres L, Stephens ML, et al. Persistent COVID-19-associated neurocognitive symptoms in non- hospitalized patients. J Neurovirol. 2021; 27(1): 191-5.
  • 6. Almeria M, Cejudo JC, Sotoca J, Deus J, Krupinski J. Cognitive profile following COVID-19 infection: Clinical predictors leading to neuropsychological impairment. Brain Behav Immun Health. 2020; 9: 100163.
  • 7. Asadi-Pooya AA, Akbari A, Emami A, Lotfi M, Rostamihosseinkhani M, Nemati H, et al. Long COVID syndrome-associated brain fog. J Med Virol. 2022; 94(3): 979-84.
  • 8. Pavli A, Theodoridou M, Maltezou HC. Post-COVID Syndrome: Incidence, Clinical Spectrum, and Challenges for Primary Healthcare Professionals. Arch Med Res. 2021; 52(6): 575-81.
  • 9. Hampshire A, Chatfield DA, MPhil AM, Jolly A, Trender W, Hellyer PJ, et al. Multivariate profile and acute-phase correlates of cognitive deficits in a COVID-19 hospitalised cohort. EClinicalMedicine. 2022; 47: 101417.
  • 10. Woo MS, Malsy J, Pöttgen J, Seddiq Zai S, Ufer F, Hadjilaou A, et al. Frequent neurocognitive deficits after recovery from mild COVID-19. Brain Commun. 2020; 2(2): fcaa205.
  • 11. Ceban F, Ling S, Lui LMW, Lee Y, Gill H, Teopiz KM, et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta- analysis. Brain Behav Immun. 2022; 101: 93-135.
  • 12. Bertuccelli M, Ciringione L, Rubega M, Bisiacchi P, Masiero S, Del Felice A. Cognitive impairment in people with previous COVID-19 infection: A scoping review. Cortex. 2022; 154: 212-30.
  • 13. Schilling C, Meyer-Lindenberg A, Schweiger JI. Cognitive disorders and sleep disturbances in long COVID. Der Nervenarzt. 2022; 93(8): 779-87.
  • 14. Daroische R, Hemminghyth MS, Eilertsen TH, Breitve MH, Chwiszczuk LJ. Cognitive Impairment After COVID-19-A Review on Objective Test Data. Front Neurol. 2021; 12: 699582.
  • 15. Biagianti B, Di Liberto A, Nicolò Edoardo A, Lisi I, Nobilia L, de Ferrabonc GD, et al. Cognitive Assessment in SARS-CoV-2 Patients: A Systematic Review.Front Aging Neurosci. 2022; 14: 909661.
  • 16. Gündüz H, Gündüz GB, Kaya H, Inal Ö, Gülveren H, Tavat BC. Norm Determination Study of Trail Making Test, Enhanced Cued Recall Test and Clock Drawing Test for Turkish Sample Between 6-18 Years of Age. Noro Psikiyatr Ars. 2021; 58(4): 314-20.
  • 17. Saka E, Mihci E, Topcuoglu MA, Balkan S. Enhanced cued recall has a high utility as a screening test in the diagnosis of Alzheimer’s disease and mild cognitive impairment in Turkish people. Arch Clin Neuropsychol. 2006; 21(7): 745-51.
  • 18. Rawal G, Yadav S, Kumar R. Post-intensive Care Syndrome: an Overview. J Transl Int Med. 2017; 5(2): 90-2.
  • 19. Del Brutto OH, Wu S, Mera RM, Costa AF, Recalde BY, Issa NP. Cognitive decline among individuals with history of mild symptomatic SARS-CoV-2 infection: A longitudinal prospective study nested to a population cohort. Eur J Neurol. 2021; 28(10): 3245-53.
  • 20. Alemanno F, Houdayer E, Parma A, Spina A, Del Forno A, Scatolini A, et al. COVID-19 cognitive deficits after respiratory assistance in the subacute phase: A COVID-rehabilitation unit experience. PLoS One. 2021; 16(2): e0246590.
  • 21. Ferrucci R, Dini M, Rosci C, Capozza A, Groppo E, Reitano MR, et al. One-year cognitive follow-up of COVID-19 hospitalized patients. Eur J Neurol. 2022; 29(7): 2006-14.
  • 22. Yılmaz A, Yayıcı Köken Ö, Şekeroğlu B, Şanlıdağ B. A Near-Global Slowing of Background Activity and Epileptic Discharges in Children with Mild to Moderately Symptomatic COVID-19 Infection: An Electro-Neurophysiological Study. Clin EEG Neurosci. 2022; 53(6): 532-42.
  • 23. Anokhin A, Vogel F. EEG Alpha Rhythm Frequency and Intelligence in Normal Adults. Intelligence. 1996;23(1):1-14.
  • 24. Menon V. Developmental cognitive neuroscience of arithmetic: implications for learning and education. ZDM. 2010; 42(6): 515-25.
  • 25. Antonelli M, Penfold RS, Merino J, Sudre CH, Molteni E, Berry S, et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis. 2022; 22(1): 43-55.
  • 26. Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022; 604(7907): 697-707.
APA TASKIRAN SAG A (2023). COVID-19 Associated Brain Fog and Neurocognitive Assessment. , 115 - 120. 10.4274/cjms.2023.2022-74
Chicago TASKIRAN SAG Aslihan COVID-19 Associated Brain Fog and Neurocognitive Assessment. (2023): 115 - 120. 10.4274/cjms.2023.2022-74
MLA TASKIRAN SAG Aslihan COVID-19 Associated Brain Fog and Neurocognitive Assessment. , 2023, ss.115 - 120. 10.4274/cjms.2023.2022-74
AMA TASKIRAN SAG A COVID-19 Associated Brain Fog and Neurocognitive Assessment. . 2023; 115 - 120. 10.4274/cjms.2023.2022-74
Vancouver TASKIRAN SAG A COVID-19 Associated Brain Fog and Neurocognitive Assessment. . 2023; 115 - 120. 10.4274/cjms.2023.2022-74
IEEE TASKIRAN SAG A "COVID-19 Associated Brain Fog and Neurocognitive Assessment." , ss.115 - 120, 2023. 10.4274/cjms.2023.2022-74
ISNAD TASKIRAN SAG, Aslihan. "COVID-19 Associated Brain Fog and Neurocognitive Assessment". (2023), 115-120. https://doi.org/10.4274/cjms.2023.2022-74
APA TASKIRAN SAG A (2023). COVID-19 Associated Brain Fog and Neurocognitive Assessment. Cyprus Journal of Medical Sciences, 8(2), 115 - 120. 10.4274/cjms.2023.2022-74
Chicago TASKIRAN SAG Aslihan COVID-19 Associated Brain Fog and Neurocognitive Assessment. Cyprus Journal of Medical Sciences 8, no.2 (2023): 115 - 120. 10.4274/cjms.2023.2022-74
MLA TASKIRAN SAG Aslihan COVID-19 Associated Brain Fog and Neurocognitive Assessment. Cyprus Journal of Medical Sciences, vol.8, no.2, 2023, ss.115 - 120. 10.4274/cjms.2023.2022-74
AMA TASKIRAN SAG A COVID-19 Associated Brain Fog and Neurocognitive Assessment. Cyprus Journal of Medical Sciences. 2023; 8(2): 115 - 120. 10.4274/cjms.2023.2022-74
Vancouver TASKIRAN SAG A COVID-19 Associated Brain Fog and Neurocognitive Assessment. Cyprus Journal of Medical Sciences. 2023; 8(2): 115 - 120. 10.4274/cjms.2023.2022-74
IEEE TASKIRAN SAG A "COVID-19 Associated Brain Fog and Neurocognitive Assessment." Cyprus Journal of Medical Sciences, 8, ss.115 - 120, 2023. 10.4274/cjms.2023.2022-74
ISNAD TASKIRAN SAG, Aslihan. "COVID-19 Associated Brain Fog and Neurocognitive Assessment". Cyprus Journal of Medical Sciences 8/2 (2023), 115-120. https://doi.org/10.4274/cjms.2023.2022-74